News
First Oral HER2 NSCLC Therapy Zongertinib Wins FDA Approval
New York | August 14, 2025 — The U.S. Food and Drug Administration (FDA) has granted accelerated approval to zongertinib (Hernexeos, Boehringer Ingelheim Pharmaceuticals, Inc.).
Read More